The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 28, 2025

Filed:

Dec. 05, 2019
Applicant:

The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);

Inventors:

Crystal Mackall, Stanford, CA (US);

Louai Labanieh, Palo Alto, CA (US);

Robbie Majzner, Palo Alto, CA (US);

Michael Z. Lin, Stanford, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/705 (2006.01); A61K 38/05 (2006.01); A61K 38/17 (2006.01); A61K 39/395 (2006.01); A61K 40/11 (2025.01); A61K 40/31 (2025.01); A61K 40/42 (2025.01); C07K 14/005 (2006.01); C07K 14/725 (2006.01); C07K 16/28 (2006.01); C07K 16/46 (2006.01); C07K 19/00 (2006.01); C12N 5/0783 (2010.01); A61K 39/00 (2006.01); A61K 40/15 (2025.01); A61K 40/32 (2025.01);
U.S. Cl.
CPC ...
C07K 14/7051 (2013.01); A61K 38/05 (2013.01); A61K 38/177 (2013.01); A61K 38/1774 (2013.01); A61K 39/3955 (2013.01); A61K 40/11 (2025.01); A61K 40/31 (2025.01); A61K 40/4205 (2025.01); A61K 40/4211 (2025.01); A61K 40/4258 (2025.01); C07K 14/005 (2013.01); C07K 14/705 (2013.01); C07K 14/70517 (2013.01); C07K 14/70521 (2013.01); C07K 14/70578 (2013.01); C07K 16/2827 (2013.01); C07K 16/46 (2013.01); C07K 19/00 (2013.01); C12N 5/0636 (2013.01); C12N 5/0646 (2013.01); A61K 2039/505 (2013.01); A61K 40/15 (2025.01); A61K 40/32 (2025.01); A61K 2239/10 (2023.05); A61K 2239/23 (2023.05); A61K 2239/31 (2023.05); A61K 2239/38 (2023.05); A61K 2239/48 (2023.05); C07K 2317/622 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01); C07K 2319/30 (2013.01); C07K 2319/33 (2013.01); C07K 2319/50 (2013.01); C12N 2770/24232 (2013.01); C12N 2770/24271 (2013.01);
Abstract

Provided herein are cell surface receptors that include an extracellular binding domain, a transmembrane domain, an intracellular signaling domain, and a protease cleavage site disposed between the extracellular binding domain and the intracellular signaling domain. In certain aspects, the cell surface receptors are engineered cell surface receptors, such as chimeric antigen receptors (CARs). Also provided are cells that include such receptors (e.g., where the cells express the receptors on their surface) and pharmaceutical compositions including such cells. Nucleic acids that encode the cell surface receptors, cells including such nucleic acids, and pharmaceutical compositions including such cells, are also provided. Also provided are methods for regulating signaling of a cell surface receptor, and methods of using the cells of the present disclosure, including methods of using such cells to administer a regulatable cell-based therapy to an individual.


Find Patent Forward Citations

Loading…